Zero Candida Technologies, Inc.

C$0.11As of Sun 8 Nov 2026, 12:00 UTC

TSXV:ZCTHealthcare

Country Canada

PE (Fwd) —

TSR 10Y CAGR —

Div yield —

ROE (55.20%)

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM (54.17%)

Mkt cap C$2.149M

ROIC (77.02%)

SE Grade™

—

Value

—

Quality

Moat

1Y Price

Reference

$0.119

—

7.80%

—

TTM

FYE 31 Dec CAD

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

◌—

Revenue$M

—

◌—

—

Revenue growth%

—

Gross margin%

—

Operating margin%

—

Net margin%

—

P/E ratio (avg)x

—

EV/EBITx

—

(35.74)

FCF yield (avg)%

—

(8.75)

(11.74)

—

(10.25)

—

FCF margin%

—

0.746

FCF / Net incomex

—

0.266

—

0.150

0.746

—

0.208

—

(77.02)

ROIC%

—

(105.21)

(77.02)

—

(91.12)

—

(55.20)

Return on equity%

—

(268.27)

(55.20)

—

(161.74)

—

(42.09)

Return on assets%

—

(135.12)

(195.49)

(42.09)

—

(135.12)

—

(0.05)

EPS$

—

(0.13)

—

(0.32)

(0.05)

—

83.61

EPS growth%

—

99.78

(112056.37)

83.61

—

83.61

—

0.07

Bookvalue per sh$

—

0.12

0.07

(40.65%)

—

(0.04)

FCF per share$

—

(0.03)

—

(0.05)

(0.04)

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

19.53

Shares (diluted)M

—

19.53

◌19.53

—

Buyback yield%

—

◌—

—

0.016

D/E ratiox

—

(0.264)

0.012

0.016

0.012

—

1.984

Enterprise value$M

—

10.53

6.376

1.984

(39.46%)

—

LT debt$M

—

Peers (US$1.945M)

Cap (US$)

Aurora Spine Corporati…

5.527M

—

NuGen Medical Devices…

2.410M

—

Therma Bright Inc.

1.441M

—

Vivos Therapeutics…

1.885M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

—

(15.89)

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

39.79

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

—

EPS growth years

2/3

Dividend streakyrs

Op margin range%

—

$1 testx

—

Incr. ROIC%

—

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring.

Revenue by segment

No breakdown available

Asset mix

Trend

Other

92.36%

Cash and investments

7.64%

Reinvestment returns

No breakdown available